---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-003793"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2026-05-29T20:15:18+00:00"
generated_at: "2026-05-29T20:17:32.003178+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech shareholders approve equity plan amendment adding 750K shares

## Summary
- Shareholders approved Plan Amendment increasing shares available for issuance by 750,000 and eliminating annual per participant option grant limit.
- All seven director nominees elected with over 2.6M votes for each; broker non-votes of ~2.15M on each.
- Advisory vote on executive compensation approved with 2.67M for, 69K against.
- Appointment of MNP LLP as auditors for FY2026 approved with 4.81M for.
- Approximately 55% of outstanding shares (4.9M shares) represented at the meeting.

## SEC filing metadata
- accession: 0001171843-26-003793
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2026-05-29T20:15:18+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/0001171843-26-003793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/f8k_052226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-003793
- JSON: https://secwatch.observer/filing/0001171843-26-003793.json
- Plain text: https://secwatch.observer/filing/0001171843-26-003793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.